{"transactions":[{"id":832719,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:20:31.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":2.8,"value":8400.0,"ownership":{"direct":true},"balance_after":18250,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-18","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001087294-26-000033","document":"wk-form4_1774041628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000033/wk-form4_1774041628.xml","form_type":"4"}},{"id":1201680,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2025-03-18T21:06:34.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":5.17,"value":14217.5,"ownership":{"direct":true},"balance_after":15250,"derivative":{"exercise_price":5.17,"exercise_date":"2029-03-17","expiration_date":"2035-03-17","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001628280-25-013513","document":"wk-form4_1742331988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025013513/wk-form4_1742331988.xml","form_type":"4"}},{"id":1201679,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:06:34.000Z","date":"2025-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":5930,"price":5.46,"value":32377.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":20073,"source":{"system":"sec-edgar","filing":"0001628280-25-013513","document":"wk-form4_1742331988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025013513/wk-form4_1742331988.xml","form_type":"4"}},{"id":1561031,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2024-03-27T00:22:47.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":1.71,"value":9405.0,"ownership":{"direct":true},"balance_after":12500,"derivative":{"exercise_price":1.71,"exercise_date":"2028-03-25","expiration_date":"2034-03-25","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001214659-24-005208","document":"marketforms-65389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000121465924005208/marketforms-65389.xml","form_type":"4"}},{"id":1561030,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-27T00:22:47.000Z","date":"2024-03-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":445,"price":1.81,"value":805.45,"ownership":{"direct":true},"balance_after":26003,"source":{"system":"sec-edgar","filing":"0001214659-24-005208","document":"marketforms-65389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000121465924005208/marketforms-65389.xml","form_type":"4"}},{"id":1720509,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-06T22:05:36.000Z","date":"2023-11-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":352,"price":1.67,"value":587.84,"ownership":{"direct":true},"balance_after":26448,"source":{"system":"sec-edgar","filing":"0001214659-23-016106","document":"marketforms-63729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000121465923016106/marketforms-63729.xml","form_type":"4"}},{"id":1938313,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2023-03-27T21:53:39.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% vesting on March 24, 2027."}],"balance_after":7000,"derivative":{"exercise_price":1.97,"exercise_date":"2027-03-24","expiration_date":"2033-03-24","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-23-021290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919123021290/doc4.xml","form_type":"4"}},{"id":2288130,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2022-04-29T17:02:43.000Z","date":"2022-03-16","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"100% vesting on March 16, 2026."}],"balance_after":2000,"derivative":{"exercise_price":2.59,"exercise_date":"2026-03-16","expiration_date":"2032-03-16","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-22-026140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122026140/doc4.xml","form_type":"4"}},{"id":2288129,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-29T17:02:43.000Z","date":"2022-03-16","kind":"grant","acquired":true,"shares":20000,"price":2.59,"value":51800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% vesting on March 16, 2025."}],"balance_after":26800,"source":{"system":"sec-edgar","filing":"0001209191-22-026140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122026140/doc4.xml","form_type":"4"}},{"id":2486965,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56920,"kind":"person","name":"Hamm John M.","position":1,"cik":"0001870439","reported_name":"Hamm John M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-03T22:15:41.000Z","date":"2021-11-23","kind":"purchase","acquired":true,"shares":3800,"price":2.35,"value":8930.0,"ownership":{"direct":true},"balance_after":6800,"source":{"system":"sec-edgar","filing":"0001209191-21-067905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121067905/doc4.xml","form_type":"4"}}]}